Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Canadian Health Industry News.
Press releases published on August 1, 2025
Four Incredible Films to be Shown at International Association for Near-Death Studies Conference in Oak Brook
EIN Presswire
·
August 1, 2025
Raymond Moody, MD, Ph.D., to Deliver Remarks August 28 Just Before Screening of Film About His Groundbreaking Near-Death Experience Research DURHAM, NORTH CAROLINA, NC, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- Four incredible films about near …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Sirona Biochem Update to Shareholders on Financial Status and Operations
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial position and recent corporate developments. The …
Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call
GlobeNewswire
·
August 1, 2025
MONTREAL, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2025 financial results on Thursday, August 7, 2025 prior to market opening …
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du deuxième trimestre 2025
GlobeNewswire
·
August 1, 2025
MONTRÉAL, 01 août 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), publiera ses résultats financiers du deuxième trimestre 2025, ce jeudi 7 août 2025 avant l’ …
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
GlobeNewswire
·
August 1, 2025
Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by exceeding ORR benchmarks demonstrated …